SNTI (STOCKS)
Senti Biosciences Holdings, Inc. Common Stock
$0.383700
+0.008500 (+2.27%)
Prev close: $0.375200
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Timothy K. Lu
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $12.12M
- Employees
- 48
- P/E (TTM)
- -0.20
- P/B (TTM)
- 4.56
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
3
Strong Buy
5
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Mar 2026 (Q1)
|
$-0.36 | $-0.37 | +0.0072 | +1.96% |
|
Dec 2025 (Q4)
|
$-0.53 | $-0.42 | -0.1092 | -25.95% |
|
Sep 2025 (Q3)
|
$-0.69 | $-0.58 | -0.1120 | -19.38% |
|
Jun 2025 (Q2)
|
$-0.56 | $-0.92 | +0.3580 | +39.00% |
Financial Statements
| Revenues | $38.00K |
| Nonoperating Income/Loss | $5.45M |
| Operating Expenses | $57.04M |
| Research and Development | $33.59M |
| Operating Income/Loss | -$57.00M |
| Income/Loss From Continuing Operations After Tax | -$51.55M |
| Income/Loss From Continuing Operations Before Tax | -$51.55M |
| Income Tax Expense/Benefit | $0.00 |
| Net Income/Loss | -$51.55M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$51.55M |
| Net Income/Loss Available To Common Stockholders, Basic | -$51.55M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$1.87 |
| Diluted Earnings Per Share | -$1.87 |
| Basic Average Shares | 84,930,962 |
| Diluted Average Shares | 84,930,962 |
| Assets | $38.24M |
| Current Assets | $14.79M |
| Prepaid Expenses | $1.58M |
| Other Current Assets | $13.21M |
| Noncurrent Assets | $23.45M |
| Fixed Assets | $12.10M |
| Other Non-current Assets | $11.35M |
| Liabilities | $35.68M |
| Current Liabilities | $14.27M |
| Accounts Payable | $1.05M |
| Wages | $2.37M |
| Other Current Liabilities | $10.85M |
| Noncurrent Liabilities | $21.41M |
| Equity | $2.57M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $2.57M |
| Temporary Equity | $0.00 |
| Temporary Equity Attributable To Parent | $0.00 |
| Liabilities And Equity | $38.24M |
| Net Cash Flow From Operating Activities | -$36.88M |
| Net Cash Flow From Operating Activities, Continuing | -$36.88M |
| Net Cash Flow From Investing Activities | -$14.53M |
| Net Cash Flow From Investing Activities, Continuing | -$14.53M |
| Net Cash Flow From Financing Activities | $12.06M |
| Net Cash Flow From Financing Activities, Continuing | $12.06M |
| Net Cash Flow | -$39.35M |
| Net Cash Flow, Continuing | -$39.35M |
| Comprehensive Income/Loss | -$51.55M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$51.55M |
| Other Comprehensive Income/Loss | -$36.81M |